Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2006 Sep;55(9):1224-5.
doi: 10.1136/gut.2006.093302.

Tacrolimus--finally!

K R Herrlinger  1 , K Fellermann, E F Stange
Affiliations
Comment

Tacrolimus--finally!

K R Herrlinger et al. Gut. 2006 Sep.

Abstract

Tacrolimus appears to be at least comparable to ciclosporin in refractory ulcerative colitis in terms of tolerability and efficacy but the oral route of administration and reliability of drug levels are advantageous

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment on

References

    1. Ogata H, Matsui T, Nakamura M.et al A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006551255–1262. - PMC - PubMed
    1. Fellermann K, Ludwig D, Stahl M.et al Steroid‐unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus. Am J Gastroenterol 1998931860–1866. - PubMed
    1. Fellermann K, Tanko Z, Herrlinger K R.et al Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 20028317–324. - PubMed
    1. Baumgart D C, Wiedenmann B, Dignass A U. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003171273–1281. - PubMed
    1. Ardizzone S, Maconi G, Russo A.et al Randomised controlled trial of azathioprine and 5‐aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 20065547–53. - PMC - PubMed

MeSH terms